 concomit chemotherapi split-cours radiat cure preserv speech swallow head neck cancer abil simultan cisplatin radiat surgeri radiat advanc head neck cancer phase II studi subgroup patient primari diseas hemiglossectomi laryngectomi control patient stage IV stage iii diseas tongu hypopharynx larynx primari treatment concurr cisplatin split-cours radiat week total cycl week median follow-up year patient preserv speech and/or function median surviv month patient aliv diseas free dead cancer dead caus overal failur rate advanced-stag presenc nodal diseas cycl chemotherapi failur rate program concomit cisplatin radiat control rate competit surgeri radiat appropri definit test random trial